Manolo Beelke & Partners aligns medical, regulatory, payer, commercial and operational logic so clinical programs can survive contact with reality.
Why MB&P exists
Strong science can still lose value when medical strategy, regulatory expectations, payer requirements, operational feasibility and financing decisions are developed separately. MB&P brings these perspectives into one decision-grade development architecture. We identify the assumptions most likely to undermine a program, clarify what evidence is truly required and connect strategy with the governance needed to protect execution through database lock.
FROM CLIENT PROBLEM TO DECISION CONTROL
Clients do not need another layer of capability descriptions. They need a disciplined path from a high-stakes question to evidence and execution they can defend. The operating model expands only where the interfaces create material risk.
01 · BRING THE DECISION
A pivotal design, failing trial, regulatory inflection, investment question or evidence gap.
02 · DIAGNOSE THE REAL RISK
Separate biological uncertainty from design, feasibility, payer, governance and execution risk.
03 · BUILD THE RIGHT SYSTEM
Align medical, regulatory, HTA/payer, commercial and operational logic before commitments harden.
04 · GOVERN EXECUTION
Translate strategy into country, site, vendor, quality and decision cadence through database lock.
05 · REACH THE NEXT GATE
Continue, adapt, stop, submit, finance or partner with a clearer evidence and risk position.
Senior-led operating model
The model is deliberately senior-led. MB&P pressure-tests the development logic before assumptions are locked into protocols, budgets, country plans or investor narratives. Verum translates that logic into controlled execution. NECTAR extends reach through qualified regional partners where local fluency, site access and specialist capability create real value.
01
Senior clinical architecture across medical, regulatory, payer, commercial and operational decisions.
02
The accountable project, medical, quality and sponsor-facing execution spine.
03
Qualified regional CROs, specialist vendors, healthcare providers and sites under one governance logic.
Mission and values
Independent judgment comes first. Every operating choice must preserve the ability to interpret the result, defend it to regulators and payers and make the next capital-allocation decision.
Global execution
NECTAR connects MB&P, Verum, regional CROs, specialist vendors, healthcare providers and qualified clinical sites within one coordinated delivery model. A central medical, operational and quality structure defines strategy, standards, escalation and governance. Local partners contribute regulatory knowledge, patient access, site relationships and execution depth.
Meet Manolo
Manolo E. Beelke, MD, PhD, brings 29+ years across clinical medicine and drug development, with more than 100 studies across Phase I-IV, PASS, epidemiology and HEOR. His work concentrates on the high-risk decisions where design, evidence and execution must hold under scrutiny.
A decision-grade next step
Start with the decision, risk or execution problem that needs a senior owner.
